Open access · CC-BY
via OpenAlex
Leveraging transcriptome-based biological aging clocks and mRNA signatures for the development of longevity medicines
Iman Man Hu, Arwen W. Gao, Riekelt Hootkooper, Georges E. Janssens
· 2026
Abstract
Aging is a complex phenomenon involving a gradual decline in physical, mental, and reproductive functions, and a higher risk of disease. While chronological age is a simple index of functional health, biological age can better account for individual differences influenced by genetics, lifestyle, and environment. This review focuses on messenger RNA (mRNA) transcriptome-based approaches to estimating biological age. We describe advances, challenges, and opportunities in transcriptome-based biological aging clocks trained on human and worm datasets. Stemming from this, we furthermore describe how mRNA signatures have been used for the development of longevity medicines. This includes compounds that transcriptionally reverse the mRNA signatures of aging, or mimic mRNA signatures of longevity. Compounds identified through these efforts include HSP90 inhibitors monorden and tanespemycin, calorie restriction mimetic allantoin, HDAC inhibitor cmpd60, as well as atracurium, zidovudine, and low dose naltrexone. In conclusion, mRNA signatures effectively serve biological age clocks as well as longevity medicine development.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.63751/i9ge
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Hu, I.M., Gao, A.W., Hootkooper, R., & Janssens, G.E. (2026). Leveraging transcriptome-based biological aging clocks and mRNA signatures for the development of longevity medicines. https://doi.org/10.63751/i9ge
Vancouver
Hu IM, Gao AW, Hootkooper R, Janssens GE. Leveraging transcriptome-based biological aging clocks and mRNA signatures for the development of longevity medicines. 2026. doi:10.63751/i9ge.
BibTeX
@article{iman2026Levera,
title = {Leveraging transcriptome-based biological aging clocks and mRNA signatures for the development of longevity medicines},
author = {Iman Man Hu and Arwen W. Gao and Riekelt Hootkooper and Georges E. Janssens},
year = {2026},
doi = {10.63751/i9ge},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in Aging 2018
Open access · OA
EXAMINING THE DIMENSIONS OF BIOLOGICAL AGE
bioRxiv (Cold Spring Harbor Laboratory) 2026
Preprint · CC-BY
Integrating supervised and unsupervised machine learning for behavior segmentation reveals latent frailty signatures and improves aging clocks in isogenic and outbred mice
Frontiers in aging 2025
Open access · OA
Biomarker integration and biosensor technologies enabling AI-driven insights into biological aging.
The Journals of Gerontology Series A 2026
Preprint · OA
Exploring Epigenetic Aging and Cognitive Change in Middle Adulthood
The journals of gerontology. Series A, Biological sciences and medical sciences 2026
Citation only
Exploring epigenetic aging and cognitive change in middle adulthood.
Ageing research reviews 2026
Citation only